What to diagnose Pulmonary Embolism??
PE is the leading
cause of maternal mortality in developed countries. The risk of PE is greatest
immediately postpartum, particularly after cesarean delivery, with a fatality
rate of nearly 15%. PE most commonly originates from DVT in the lower
extremities, occurring in nearly 50% of patients with proximal DVT. Symptoms
typically associated with PE are all common in pregnancy, such as shortness of
breath, chest pain, cough, tachypnea, and tachycardia. Because of the serious
potential consequences of PE and the increased incidence in pregnancy,
clinicians must have a low threshold for evaluation. Diagnosis starts with a
careful history and physical examination, followed by diagnostic tests to rule out
other possible etiologies, such as asthma, pneumonia, or pulmonary edema.
• Tests A) An arterial blood gas (ABG), electrocardiogram, and chest x-ray
should be performed. ABG values are altered in pregnancy and must be
interpreted using
pregnancy-adjusted normal
values. More than half of pregnant women with a documented PE have a normal
alveolar-arterial gradient.A chest x-ray helps rule out other disease
processes and enhances interpretation of the ventilation-perfusion (V/Q) scan.
The risks associated with various radiologic tests indicated for PE workup are
minimal compared with the consequences of a missed PE.
Tests
B:--Pulmonary angiography is not usually doe though
this is the gold standard
for PE diagnosis, but it is expensive and invasive.
Tests C : CT Angio:-- Computed tomographic (pulmonary)
angiography (CTA) is becoming the
recommended imaging test in pregnant women with suspected PE. CTA is easier to
perform, more readily available, more cost-effective, and provides a lower dose
of radiation to the fetus than a V/Q scan. CT Angio is also useful in detecting other
abnormalities that may be contributing to the patients symptoms (e.g., pneumonia,
aortic dissection). Newer technology, multidetector computed tomography
pulmonary angiography, allows visualization of finer pulmonary vascular detail
and provides greater diagnostic accuracy.
, Tests D: the V/Q scan has been the primary diagnostic test
for PE. It is interpreted as low, intermediate, or high probability for PE. High-probability scans
(i.e., segmental perfusion defect with normal ventilation) confirm PE, with a
positive predictive value over 90% when pretest likelihood is high. V/Q scans
are limited in their usefulness because of the large proportion of
indeterminate results. Most fetal radiation exposure occurs when radioactive
tracers are excreted in the maternal bladder. Therefore, exposure can be
limited by prompt and frequent voiding after the procedure. If patient is
postpartum and breast-feeding, breast milk should not be used for 2 days after
a V/Q scan.
Tests
E:
Bilateral venous duplex imaging of
the lower extremities
If a pregnant woman has a nondiagnostic lung scan, bilateral venous duplex
imaging of the lower extremities
is recommended to evaluate for DVT. If DVT is found, PE can be diagnosed. If no
DVT is seen, arteriography
may be performed for further
evaluation before a commitment to long-term anticoagulation is made, or venous
duplex imaging may be repeated in 1 week.
How safe is radiation??
According to the Centers for Disease Control and Prevention, in all stages of
gestation, a dose of <5 rads (0.05 Gy) represents no measurable noncancer
health effects. After 16 weeks’ gestation, congenital effects arc unlikely
below 50 rads. The risk for childhood cancer from prenatal radiation exposure is 0.3% to 1% for 0 to 5 rads. Any of the
proposed modalities for diagnosis of PE are well below the dose levels that increase
congenital abnormalities. Radiation exposure from a two-view chest radiograph
is <0.001 rad. A higher dose of fetal radiation is provided with V/Q scan (0.064
to 0.08 rad) compared with CTA (0.0003 to 0.0131 rad). Pulmonary angiography
provides approximately 0.2 to 0.4 rad with the femoral approach and <0.05
rad with the brachial approach. Maternal radiation dose is higher with CTA than
V/Q scan.
No comments:
Post a Comment